Description of Collaborative Activity: |
The Working Group focuses on coordinating Tuberculosis (TB) research, which includes studies to characterize drug resistance; the identification, preclinical development and clinical evaluation of new drugs, diagnostics, and vaccines; and studies of the epidemiology and transmission of TB, including research addressing HIV/TB co-infection and TB in high-risk populations. |
NIH Participating Institutes/Centers/Office of the Director: |
FIC, NHLBI, NIAID, NICHD, NIDA |
